The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest

(1) Background: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors constitute a novel drug class with remarkable cardiovascular benefits for patients with chronic heart failure (HF). Recently, this class has been utilized in acute HF as an additional treatment option to classic diuretics, which rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Fragakis, Nikolaos, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782870/
https://www.ncbi.nlm.nih.gov/pubmed/36556427
http://dx.doi.org/10.3390/life12122062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782870/
https://www.ncbi.nlm.nih.gov/pubmed/36556427
http://dx.doi.org/10.3390/life12122062

Ejemplares similares